Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes

Name: Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes
License: Public Domain

Novo Nordisk A/S

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes, diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 414474
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.